(Date:11/24/2009)...lue Marble Energy Corp. announced today that the c... (OPDA) were recently awarded $2 million by Washin...rd (CERB) in a private/public partnership to const...finery in Lincoln County, WA. ,, "This invest...ur biorefinery and bring over 70 green jobs to Lin...
(Date:11/24/2009)...s been met for patients with advanced-stage, or... Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris...a global biopharmaceutical company focused on endo...ve efficacy data from a Phase 2 study with its tar...rly AN-152), in patients with advanced or recurren...
(Date:11/24/2009)...re-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: SHP...ny, today,announced that it has submitted a MAA to...lfa, the company,s enzyme replacement therapy in d...ease. This is the third marketing,application for ...revious,submissions in the United States and Canad...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Genomic Health, Inc. (Nasd...mic Health,s Executive Chairman, will present at t...e in New York City on Tuesday, December 1, 2009 at...equently archived webcast of the presentation, vis...h,s website at http://investor.genomichealth.com ...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2...ith SciQuest will Save Time and Money, OAK BROOK,...hSystem Consortium (UHC), an alliance of academic ... SciQuest, a provider of e-procurement,technology ...anizations,today announced a partnership to provid... Research Procurement Program with a robust, easy-...
..., Oct. 9 Boston Scientific,Corporation (NYSE: BS...NT(TM) implantable cardioverter defibrillator (ICD...tific-branded cardiac rhythm management,device to ...D, with an enhanced AV Search Hysteresis feature, ...r pacing. This product also,contains wireless capa...
...l Advance Development of Diagnostics and Disease-M...d Macular Degeneration and Other Diseases ...W HAVEN, Conn., Oct. 9 Optherion, Inc., a company... wet Age-related Macular,Degeneration (AMD) and ot...plement system, announced today that it has raised...
Other Biology Technology:University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 3Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator 2Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator 3Optherion, Inc. Completes $37 Million Start Up Financing 2Optherion, Inc. Completes $37 Million Start Up Financing 3Optherion, Inc. Completes $37 Million Start Up Financing 4(Date:11/24/2009)..., Rocket science is opening new doors to understa...affect the hearing of a marine mammal or if they ...ial sized X-ray scanners that NASA uses to detect ...ockets is now allowing scientists to peek inside t...detailed three-dimensional replicas of a whale,s h...
(Date:11/24/2009)..., Stents that keep weakened and flabby arteries f...er six months, those stents are no longer needed -...unnecessary. Previously, doctors had no choice but...n of Tel Aviv University,s Department of Biomedica...iber platform that carries drugs where they,re nee...
(Date:11/24/2009)..., Springer and the American College of Medical To...orate on the publication of the Journal of Medica...CMT, beginning in March 2010. It was previously p... , The Journal of Medical Toxicology , an inter...dvancing the science and practice of medical toxic...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2A coating for life 2Springer and the American College of Medical Toxicology to work together 2RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 1New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 3New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 4New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 5Social background weighs heavily on teenage diet 58327 1Social background weighs heavily on teenage diet 58327 2Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Calf Liver tRNA from Novagen
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: